ArticleCureus2026
Large Pancreatic Gastrointestinal Stromal Tumor: A Diagnostic Quandary.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms typically arising from the gastrointestinal tract, most often in the stomach or small intestine. Primary pancreatic GIST is exceedingly rare, with fewer than 50 cases reported in the literature. We present a unique case of a 77-year-old female who was found to have a 6.5 cm complex mass in the left abdomen with inconclusive imaging findings. Endoscopic ultrasound (EUS) further characterized the lesion as a mixed solid and cystic mass with peripheral enhancement, but its origin remained uncertain. Pathology revealed a spindle cell type GIST. Given the diagnostic ambiguity, the patient underwent diagnostic laparoscopy, which definitively identified the mass as originating from the pancreatic tail, confirming the rare diagnosis of primary pancreatic GIST. Despite recommendations for surgical resection or treatment with imatinib, the patient declined both and chose to pursue close surveillance. The patient's clinical condition remained stable one year after initial diagnosis. This case underscores the importance of including pancreatic GIST in the differential diagnosis of atypical pancreatic masses, especially those with mixed solid and cystic components. It also highlights the role of EUS as well as laparoscopy in resolving diagnostic uncertainty for complex abdominal masses. Further studies are needed to better understand the natural history and optimal management of low-risk, asymptomatic pancreatic GISTs. This case also highlights the importance of shared decision-making in the management of conditions where guidelines are not well-developed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.